Thread: LRRK2 inhibitor discovered; animal testing to begin
View Single Post
Old 12-14-2012, 02:20 PM
olsen's Avatar
olsen olsen is offline
Senior Member
  
Join Date: Aug 2006
Posts: 1,860
15 yr Member
olsen olsen is offline
Senior Member
olsen's Avatar
 
Join Date: Aug 2006
Posts: 1,860
15 yr Member
Default LRRK2 inhibitor discovered; animal testing to begin
Newly identified compound can thwart protein implicated in Parkinson’s disease

12 Dec 2012, Posted by Yevgeniy Grigoryev |

Sergey Brin, the co-founder of Google, has an increased risk of developing Parkinson’s disease because he harbors a mutation in a protein called Leucine-rich repeat kinase 2, or LRRK2. The protein is viewed as a promising drug target to treat Parkinson’s, a progressive neurological disorder, but it’s not possible to track LRRK2 activity in the brain, making the search for targeted therapies against the disease challenging. In a new study, researchers now provide evidence for a way to measure LRRK2 activity—and a new compound that can block the damaging effects of the protein in rodent neurons...

http://blogs.nature.com/spoonful/201...#wpn-more-4111
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices.

~ Jean-Martin Charcot


The future is already here — it's just not very evenly distributed. William Gibson
olsen is offline   Reply With QuoteReply With Quote